Long-term psychosocial outcomes of low-dose CT screening: Results of the UK Lung Cancer Screening randomised controlled trial

Thorax

Volumn 71, Issue 11, 2016, Pages 996-1005

  Brain, Kate ^a   Lifford, Kate J ^a   Carter, Ben ^a   Burke, Olivia ^a   McRonald, Fiona ^b   Devaraj, Anand ^c   Hansell, David M ^c   Baldwin, David ^d   Duffy, Stephen W ^e   Field, John K ^f  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^d NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^f UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Imaging CT MRI etc; Lung Cancer; Psychology

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEPRESSION; DISTRESS SYNDROME; FEMALE; HIGH RISK POPULATION; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICALLY UNDERSERVED; PATIENT PARTICIPATION; PATIENT SATISFACTION; PILOT STUDY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SMOKING; SOCIAL PSYCHOLOGY; UNITED KINGDOM; DIAGNOSTIC IMAGING; LUNG TUMOR; MASS SCREENING; MENTAL STRESS; MIDDLE AGED; PROCEDURES; PSYCHOLOGY; QUESTIONNAIRE; RISK ASSESSMENT; X-RAY COMPUTED TOMOGRAPHY;

AGED; ANXIETY; DEPRESSION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; PILOT PROJECTS; RADIATION DOSAGE; RISK ASSESSMENT; STRESS, PSYCHOLOGICAL; SURVEYS AND QUESTIONNAIRES; TOMOGRAPHY, X-RAY COMPUTED; UNITED KINGDOM;

EID: 84979753773     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2016-208283     Document Type: Article

References (34)

1. Cancer Research UK. Lung cancer statistics. http://www. cancerresearchuk. org/health-professional/cancer-statistics/statistics-by-cancer-type/lung-cancer#heading-One (accessed 13 Nov 2015).
2. Walters S, Benitez-Majano S, Muller P, et al. Is England closing the international gap in cancer survival Brit J Cancer 2015;113:848-60.
3. Lyratzopoulos G, Abel GA, Brown CH, et al. Socio-demographic inequalities in stage of cancer diagnosis: evidence from patients with female breast, lung, colon, rectal, prostate, renal, bladder, melanoma, ovarian and endometrial cancer. Ann Oncol 2013;24:843-50.
4. Aberle DR, Adams AM, Berg CD, et al., National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409.
5. O'Connor GT, Hatabu H. Lung cancer screening, radiation, risks, benefits, uncertainty. JAMA 2012;307:2434-5.
6. Aggestrup LM, Hestbech MS, Siersma V, et al. Psychosocial consequences of allocation to lung cancer screening: a randomised controlled trial. BMJ Open 2012;2:e000663.
7. Rasmussen JF, Siersma V, Pedersen JH, et al. Psychosocial consequences in the Danish randomised controlled lung cancer screening trial (DLCST). Lung Cancer 2015;87:65-72.
8. van den Bergh KAM, Essink-Bot ML, Borsboom GJJM, et al. Long-term effects of lung cancer computed tomography screening on health-related quality of life: the NELSON trial. Eur Respir J 2011;38:154-61.
9. Taylor KL, Shelby R, Gelmann E, et al. Quality of life and trial adherence among participants in the prostate, lung, colorectal, ovarian cancer screening trial. J Natl Cancer Inst 2004;96:1083-94.
10. Byrne MM, Weissfeld J, Roberts MS. Anxiety, fear of cancer, perceived risk of cancer following lung cancer screening. Med Decis Making 2008;28:917-25.
11. van den Bergh KAM, Essink-Bot ML, Borsboom GJJM, et al. Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON). Br J Cancer 2010;102:27-34.
12. Gareen IF, Duan F, Greco EM, et al. Impact of lung cancer screening results on participant health-related quality of life and state anxiety in the National Lung Screening Trial. Cancer 2014;120:3401-9.
13. Field JK, Duffy SW, Baldwin DR, et al. UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening. Thorax 2016;71:161-70.
14. Silvestri GA, Nietert PJ, Zoller J, et al. Attitudes towards screening for lung cancer among smokers and their non-smoking counterparts. Thorax 2007;62:126-30.
15. van den Bergh KAM, Essink-Bot ML, van Klaveren RJ, et al. Informed participation in a randomised controlled trial of computed tomography screening for lung cancer. Eur Respir J 2009;34:711-20.
16. Patel D, Akporobaro A, Chinyanganya N, et al. Attitudes to participation in a lung cancer screening trial: a qualitative study. Thorax 2012;67:418-25.
17. Jonnalagadda S, Bergamo C, Lin JJ, et al. Beliefs and attitudes about lung cancer screening among smokers. Lung Cancer 2012;77:526-31.
18. Quaife SL, McEwen A, Janes SM, et al. Smoking is associated with pessimistic and avoidant beliefs about cancer: results from the International Cancer Benchmarking Partnership. Brit J Cancer 2015;112:1799-804.
19. von Wagner C, Baio G, Raine R, et al. Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2. 6 million invitations in England. Int J Epid 2011;40:712-18.
20. McRonald FE, Yadegarfar G, Baldwin DR, et al. The UK Lung Screen (UKLS): demographic profile of first 88, 897 approaches provides recommendations for population screening. Cancer Prev Res 2014;7:362-71.
21. Ali N, Lifford KJ, Carter B, et al. Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed-methods analysis of the United Kingdom Lung Cancer Screening (UKLS) trial. BMJ Open 2015; 5: e008254.
22. Lerman C, Daly M, Sands C. Mammography adherence and psychological distress among women at risk for breast cancer. J Natl Cancer Inst 1993;85:1074-80.
23. Watson M, Lloyd S, Davidson J, et al. The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer. Brit J Cancer 1999;79:868-74.
24. Brain K, Parsons E, Bennett P, et al. The evolution of worry after breast cancer risk assessment: 6-year follow-up of the TRACE study cohort. Psycho-Oncol 2011;20:984-91.
25. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361-70.
26. Holmes-Rovner M, Kroll J, Schmitt N, et al. Patient satisfaction with health care decisions: the satisfaction with decision scale. Med Decis Making 1996; 16:58-64.
27. Seaman SR, White IR. Review of inverse probability weighting for dealing with missing data. Stat Methods Med Res 2013;22:278-95.
28. Clements A, Henderson BJ, Tyndel S, et al. Diagnosed with breast cancer while on a family history screening programme: an exploratory qualitative study. Eur J Cancer Care 2008;17:245-52.
29. Cancer Research UK. Tobacco statistics. http://www. cancerresearchuk. org/health-professional/cancer-statistics/risk/tobacco#heading-One (accessed 13 Nov 2015).
30. Office for National Statistics. Do smoking rates vary between more and less advantaged areas http://www. ons. gov. uk/ons/rel/disability-and-health-measurement/do-smoking-rates-vary-between-more-and-less-advantaged-areas-/2012/index. html (accessed 13 Nov 2015).
31. Shack L, Jordan C, Thomson CS, et al. Variation in incidence of breast, lung and cervical cancer and malignant melanoma of skin by socioeconomic group in England. BMC Cancer 2008;8:271.
32. Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, age-based disparities. JAMA 2004;291:2720-6.
33. Hestbech MS, Siersma V, Dirksen A, et al. Participation bias in a randomised trial of screening for lung cancer. Lung Cancer 2011;73:325-31.
34. Field JK, van Klaveren R, Pedersen JH, et al. European randomized lung cancer screening trials: post NLST. J Surg Oncol 2013;108:280-6.